DPDimitrios ParaskevisPhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018HIV transmission in the migrant population- Dimitrios Paraskevis, PhDView Slideset
PCPep CollMDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Long acting HIV drugs for prevention: what are the data?- Pep Coll, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018How would the epidemic evolve in the future- David van de VijverView Slideset
OSOana SăndulescuMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018The HIV epidemic in CEE countries- Oana Săndulescu, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017NASH and NAFLD in HIV: same or different? - Mariana Machado, MDView Slideset
JRJürgen RockstrohMDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017What challenges remain in viral hepatitis- Jürgen Rockstroh, MDView Slideset
NCNikoloz ChkhartishviliMD, MS, PhDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017HCV elimination program in Georgia: Successes and challenges- Nikoloz Chkhartishvili, MD, MS, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Regression of liver fibrosis in patients with chronic hepatitis C treated with direct acting anti-viral (DAA) therapy in the country of Georgia- E. DolmazashviliView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Treatment of cirrhotic HCV/HIV co-infected patients with DAAs- R. Sarmento e CastroView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Hepatic steatosis AND Lipid proFile evolution After Hepatitis C treatment in HCV/HIV coinfected patients- J. MéndezView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Antifibrotics and fatty liver drugs in the pipeline- Sanjay Bhagani, MDView Slideset
DDDouglas DieterichMDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017Case based debate: Is HCC increased with DAA therapy? Pro stance- Douglas Dieterich, MDView Slideset
